Immune Response after 2 Doses of BNT162b2 mRNA COVID-19 Vaccinations in Children and Adolescents with Cancer and Hematologic Diseases.

Hansamon Poparn,Chonlatis Srichumpuang,Darintr Sosothikul,Watsamon Jantarabenjakul,Supanun Lauhasurayotin,Piti Techavichit,Kanhatai Chiangthong,Yong Poovorawan

Asian Pacific journal of cancer prevention : APJCP（2022）

引用 8|浏览7

暂无评分

摘要

After complete vaccination, the seroprotective rate and antibody level in pediatric and adolescent patients with cancer and hematologic disease who receive immunosuppressive agents are quite low, compared with patients who had complete treatment. Additional dose of primary series should be offered.

查看译文

关键词

Pediatric cancer,SARS-CoV-2 vaccine,delta strain,immunogenicity,mRNA COVID-19 vaccine

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要